Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Inflammation × Other × Clear all

Phase

Phase NA 3 Phase 4 3 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 5 Genitourinary 2 CNS 2 Other hematologic neoplasm 1 Other 1 Lymphoid 1 Gastrointestinal 1

Conditions

Mucositis 35 Obesity 22 Neoplasms 15 Head and Neck Neoplasms 12 Dyspnea 11 Stomatitis 9 Constipation 8 Squamous Cell Carcinoma of Head and Neck 7 Sexual Dysfunction, Physiological 6 Overweight 6 Breast Neoplasms 6 Xerostomia 5 Radiation Injuries 4 Opioid-Induced Constipation 4 Prostatic Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Nausea 3 Mouth Neoplasms 3 Colorectal Neoplasms 3 Tongue Neoplasms 2 Salivary Gland Neoplasms 2 Polycystic Ovary Syndrome 2 Pain 2 Multiple Myeloma 2 Leukemia 2 Hematologic Neoplasms 2 Febrile Neutropenia 2 Endometrial Neoplasms 2 Endometrial Hyperplasia 2 Craniopharyngioma 2

Interventions

Tablets 1 Specimen Handling 1 Pregabalin 1 Omeprazole 1 Ketorolac 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06150898 2025-06-13

KePreSt

Jules Bordet Institute

Phase 2 Recruiting

Breast Neoplasms, Inflammation, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡